SEC Info - Nymox Pharmaceutical Corp - ‘20-F’ for 12/31/06

SEC Info℠

Home

Help

Please Sign In

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/06

On: Tuesday, 6/26/07, at 1:06pm ET · For: 12/31/06 · Accession #: 897069-7-1446 · File #: 1-12033

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/26/07  Nymox Pharmaceutical Corp         20-F       12/31/06    5:1.0M                                   Foley & Lardner/FA

Annual Report of a Foreign Private Issuer — Form 20-F
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report                                       HTML    951K 
 2: EX-12.(A)   Statement re: Computation of Ratios                 HTML     10K 
 3: EX-12.(B)   Statement re: Computation of Ratios                 HTML     10K 
 4: EX-13.(A)   Annual or Quarterly Report to Security Holders      HTML      6K 
 5: EX-13.(B)   Annual or Quarterly Report to Security Holders      HTML      6K

Filing Submission 0000897069-07-001446 – SGML Text

Original SGML Text submitted by:	Foley & Lardner/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/06

On: Tuesday, 6/26/07, at 1:06pm ET · For: 12/31/06 · Accession #: 897069-7-1446 · File #: 1-12033

Previous ‘20-F’: ‘20-F’ on 6/30/06 for 12/31/05 · Next: ‘20-F’ on 4/28/08 for 12/31/07 · Latest: ‘20-F’ on 5/2/23 for 12/31/22

Annual Report of a Foreign Private Issuer — Form 20-FFiling Table of Contents

To view the SGML, please refresh this page.

Annual Report of a Foreign Private Issuer — Form 20-F
Filing Table of Contents

To view the SGML, please refresh
this page.